Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice.

Maidji E, Moreno ME, Rivera JM, Joshi P, Galkina SA, Kosikova G, Somsouk M, Stoddart CA.

Viruses. 2019 Mar 13;11(3). pii: E256. doi: 10.3390/v11030256.

2.

Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.

Stoddart CA, Galkina SA, Joshi P, Kosikova G, Moreno ME, Rivera JM, Sloan B, Reeve AB, Sarafianos SG, Murphey-Corb M, Parniak MA.

Antimicrob Agents Chemother. 2015 Jul;59(7):4190-8. doi: 10.1128/AAC.05036-14. Epub 2015 May 4.

3.

CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.

Laing ST, Griffey SM, Moreno ME, Stoddart CA.

J Comp Pathol. 2015 Feb-Apr;152(2-3):238-42. doi: 10.1016/j.jcpa.2014.12.010. Epub 2015 Feb 7.

PMID:
25670669
4.

Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice.

Stoddart CA, Galkina SA, Joshi P, Kosikova G, Long BR, Maidji E, Moreno ME, Rivera JM, Sanford UR, Sloan B, Cieplak W, Wrin T, Chan-Hui PY.

Virology. 2014 Aug;462-463:115-25. doi: 10.1016/j.virol.2014.05.036. Epub 2014 Jun 25.

5.

Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.

García-Cadenas I, Valcárcel D, Martino R, Piñana JL, Novelli S, Esquirol A, Garrido A, Moreno ME, Granell M, Moreno C, Saavedra S, Briones J, Brunet S, Sierra J.

Biol Blood Marrow Transplant. 2013 Mar;19(3):435-9. doi: 10.1016/j.bbmt.2012.11.012. Epub 2012 Nov 20.

6.

Environmental exposure to lead and mercury in Mexican children: a real health problem.

Acosta-Saavedra LC, Moreno ME, Rodríguez-Kessler T, Luna A, Arias-Salvatierra D, Gómez R, Calderon-Aranda ES.

Toxicol Mech Methods. 2011 Nov;21(9):656-66. doi: 10.3109/15376516.2011.620997. Epub 2011 Oct 10. Review.

PMID:
21981766
7.

Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice.

Stoddart CA, Maidji E, Galkina SA, Kosikova G, Rivera JM, Moreno ME, Sloan B, Joshi P, Long BR.

Virology. 2011 Aug 15;417(1):154-60. doi: 10.1016/j.virol.2011.05.013.

8.

Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists.

Majem M, Moreno ME, Calvo N, Feliu A, Pérez J, Mangues MA, Barnadas A.

Support Care Cancer. 2011 Dec;19(12):1983-90. doi: 10.1007/s00520-010-1042-3. Epub 2010 Nov 18.

PMID:
21086141
9.

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

BMC Infect Dis. 2010 Sep 14;10:267. doi: 10.1186/1471-2334-10-267.

10.

Biomonitoring of metal in children living in a mine tailings zone in Southern Mexico: A pilot study.

Moreno ME, Acosta-Saavedra LC, Meza-Figueroa D, Vera E, Cebrian ME, Ostrosky-Wegman P, Calderon-Aranda ES.

Int J Hyg Environ Health. 2010 Jul;213(4):252-8. doi: 10.1016/j.ijheh.2010.03.005. Epub 2010 Apr 24.

PMID:
20418157
11.

[Factors related to non-prescription of tuberculin skin testing in a cohort of HIV-infected people].

Díaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):215-21. doi: 10.1016/j.eimc.2009.06.008. Epub 2009 Aug 15. Spanish.

PMID:
19683364
12.

Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients.

Roman-Gonzalez A, Moreno ME, Alfaro JM, Uribe F, Latorre-Sierra G, Rugeles MT, Montoya CJ.

Hum Immunol. 2009 Apr;70(4):262-8. doi: 10.1016/j.humimm.2009.01.012. Epub 2009 Jan 27.

PMID:
19480856
13.

Nursing care for adaptation.

Moreno ME, Durán MM, Hernandez A.

Nurs Sci Q. 2009 Jan;22(1):67-73. doi: 10.1177/0894318408327296. Review.

PMID:
19176862
14.

Residues near the amino terminus of Rns are essential for positive autoregulation and DNA binding.

Basturea GN, Bodero MD, Moreno ME, Munson GP.

J Bacteriol. 2008 Apr;190(7):2279-85. doi: 10.1128/JB.01705-07. Epub 2008 Jan 25.

15.

Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells.

Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT.

Clin Immunol. 2008 Mar;126(3):243-50. doi: 10.1016/j.clim.2007.11.004. Epub 2008 Jan 16.

PMID:
18201932
16.

Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain.

Diez M, Diaz A, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaria JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

Int J Tuberc Lung Dis. 2007 Nov;11(11):1196-202.

PMID:
17958981
17.

Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.

Stoddart CA, Bales CA, Bare JC, Chkhenkeli G, Galkina SA, Kinkade AN, Moreno ME, Rivera JM, Ronquillo RE, Sloan B, Black PL.

PLoS One. 2007 Aug 1;2(7):e655.

18.

Nursing, healthcare, and culture: a view for the year 2050 from Colombia.

Fawcett J, Moreno ME.

Nurs Sci Q. 2007 Apr;20(2):144-7.

PMID:
17442863
19.

Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.

Piñana JL, Valcárcel D, Martino R, Moreno ME, Sureda A, Briones J, Brunet S, Sierra J.

Biol Blood Marrow Transplant. 2006 Nov;12(11):1135-41. Erratum in: Biol Blood Marrow Transplant. 2007 Jan;13(1):124.

20.

Continuous peripheral nerve blockade in lower extremity surgery.

Navas AM, Gutiérrez TV, Moreno ME.

Acta Anaesthesiol Scand. 2005 Sep;49(8):1048-55. Review.

PMID:
16095441
21.

The effect of the presence of volatile organoselenium compounds on the determination of inorganic selenium by hydride generation.

Moreno ME, Pérez-Conde C, Cámara C.

Anal Bioanal Chem. 2003 Mar;375(5):666-72. Epub 2003 Feb 19.

PMID:
12638051
22.

Complementary DNA sequence of the HLA-B*3924 allele.

Estefanía E, Gómez-Lozano N, de Pablo R, Moreno ME, Vilches C.

Eur J Immunogenet. 2003 Feb;30(1):11-2.

PMID:
12558815
23.

Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis.

Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C, Xu W, Yonemoto W, Bresnahan PA, McCune JM, Greene WC.

J Virol. 2003 Feb;77(3):2124-33.

24.

Insecticide formulations based on nicotine oleate stabilized by sodium caseinate.

Casanova H, Ortiz C, Peláez C, Vallejo A, Moreno ME, Acevedo M.

J Agric Food Chem. 2002 Oct 23;50(22):6389-94.

PMID:
12381122
25.

Complementary DNA sequence of the novel HLA-B*3704 allele.

Estefanía E, Gómez-Lozano N, de Pablo R, Moreno ME, Vilches C.

Tissue Antigens. 2002 Feb;59(2):142-4.

PMID:
12028544
26.

[Two new cases of autochthonous hepatitis E].

Sánchez MA, Moreno ME, García Avello A, Mateos ML.

Enferm Infecc Microbiol Clin. 2002 Mar;20(3):138. Review. Spanish. No abstract available.

PMID:
11904095
27.

IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus.

Keir ME, Stoddart CA, Linquist-Stepps V, Moreno ME, McCune JM.

J Immunol. 2002 Jan 1;168(1):325-31.

28.

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.

Strizki JM, Xu S, Wagner NE, Wojcik L, Liu J, Hou Y, Endres M, Palani A, Shapiro S, Clader JW, Greenlee WJ, Tagat JR, McCombie S, Cox K, Fawzi AB, Chou CC, Pugliese-Sivo C, Davies L, Moreno ME, Ho DD, Trkola A, Stoddart CA, Moore JP, Reyes GR, Baroudy BM.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12718-23. Epub 2001 Oct 16.

29.
30.

Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1.

Gobbi A, Stoddart CA, Locatelli G, Santoro F, Bare C, Linquist-Stepps V, Moreno ME, Abbey NW, Herndier BG, Malnati MS, McCune JM, Lusso P.

J Virol. 2000 Sep;74(18):8726-31.

31.

Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.

Stoddart CA, Moreno ME, Linquist-Stepps VD, Bare C, Bogan MR, Gobbi A, Buckheit RW Jr, Bedard J, Rando RF, McCune JM.

Antimicrob Agents Chemother. 2000 Mar;44(3):783-6.

32.

[Necrotizing pneumonia due to Salmonella sp. complicated by pneumothorax in a patient infected with the human immunodeficiency virus].

Pintado V, Navas E, Moreno L, Moreno ME.

Enferm Infecc Microbiol Clin. 1999 Dec;17(10):536-8. Review. Spanish. No abstract available.

PMID:
10650658
33.

Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.

Dittmer D, Stoddart C, Renne R, Linquist-Stepps V, Moreno ME, Bare C, McCune JM, Ganem D.

J Exp Med. 1999 Dec 20;190(12):1857-68.

34.

R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.

Berkowitz RD, van't Wout AB, Kootstra NA, Moreno ME, Linquist-Stepps VD, Bare C, Stoddart CA, Schuitemaker H, McCune JM.

J Virol. 1999 Sep;73(9):7817-22.

35.

CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo.

Berkowitz RD, Alexander S, Bare C, Linquist-Stepps V, Bogan M, Moreno ME, Gibson L, Wieder ED, Kosek J, Stoddart CA, McCune JM.

J Virol. 1998 Dec;72(12):10108-17.

36.

HLA class I and class II allele distribution in the Bubi population from the island of Bioko (Equatorial Guinea).

de Pablo R, García-Pacheco JM, Vilches C, Moreno ME, Sanz L, Rementería MC, Puente S, Kreisler M.

Tissue Antigens. 1997 Dec;50(6):593-601.

PMID:
9458112
37.

The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi population from Equatorial Guinea.

Vilches C, Bunce M, de Pablo R, Moreno ME, Puente S, Sanz L, Kreisler M.

Tissue Antigens. 1997 Jun;49(6):644-8.

PMID:
9234488
38.

A randomized double-blind clinical trial of two antivenoms in patients bitten by Bothrops atrox in Colombia. The Regional Group on Antivenom Therapy Research (REGATHER).

Otero R, Gutiérrez JM, Núñez V, Robles A, Estrada R, Segura E, Toro MF, García ME, Díaz A, Ramírez EC, Gómez G, Castañeda J, Moreno ME.

Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):696-700.

PMID:
9015522
39.

Haplotypic association of two new HLA class I alleles: Cw*15052 and B*0706: evolutionary relationships of HLA-Cw*15 alleles.

Sanz L, Vilches C, de Pablo R, Bunce M, Moreno ME, Kreisler M.

Tissue Antigens. 1996 Apr;47(4):329-32.

PMID:
8773323
40.

Molecular characterization of the new alleles HLA-B*8101 and B*4407.

Vilches C, Sanz L, de Pablo R, Moreno ME, Puente S, Kreisler M.

Tissue Antigens. 1996 Feb;47(2):139-42. No abstract available.

PMID:
8851728
41.

A novel TaqI/DQA RFLP associated with HLA-DR9, DQ9 (DQA1*0302).

Vilches C, de Pablo R, Solís R, Martín R, Herrero MJ, Moreno ME, Kreisler M.

Eur J Immunogenet. 1995 Jun;22(3):261-4.

PMID:
8547232
42.

Molecular characterization of a novel, serologically detectable, HLA-C allele: Cw*1602.

Vilches C, Herrero MJ, de Pablo R, Moreno ME, Bunce M, Kreisler M.

Hum Immunol. 1994 Oct;41(2):167-70.

PMID:
7860363
43.

A novel HLA-C allele (Cw*1504) related to the Cw6.2 phenotype.

de Pablo MR, Vilches C, Moreno ME, Kreisler M.

Immunogenetics. 1994;39(1):79. No abstract available.

PMID:
8225443
44.

Cw*1505: a novel HLA-C allele isolated from a B*7301 haplotype.

Vilches C, de Pablo R, Herrero MJ, Moreno ME, Kreisler M.

Immunogenetics. 1994;40(4):313. No abstract available.

PMID:
8082899
45.

HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27.

Vilches C, de Pablo R, Herrero MJ, Moreno ME, Kreisler M.

Immunogenetics. 1994;40(2):166. No abstract available.

PMID:
7517915
47.

Characterization of an HLA-DR15 DQ5 haplotype found in the Spanish Caucasoid population.

Vilches C, de Pablo R, Moreno ME, Solís R, Kreisler M.

Hum Immunol. 1992 Dec;35(4):223-9.

PMID:
1363423
48.

Distribution of HLA antigens in Spanish Gypsies: a comparative study.

de Pablo R, Vilches C, Moreno ME, Rementería M, Solís R, Kreisler M.

Tissue Antigens. 1992 Oct;40(4):187-96.

PMID:
1361688
49.

Is determination of the hepatic iron index of diagnostic value in patients with thalassemia minor and chronic alcoholic liver disease?

Yebra M, Lacoma F, Queipo de Llano MP, Moreno ME.

Hepatology. 1991 Jun;13(6):1264-5. No abstract available.

PMID:
2050344
50.

HLA-DR2, a marker for class I antigen sensitization.

Kreisler JM, Rementeria MC, de Pablo R, Moreno ME.

Transplantation. 1988 Jun;45(6):1071-4.

PMID:
3289149

Supplemental Content

Loading ...
Support Center